Neodjuvant Chemoimmunotherapy Takes Another Step Forward in Stage IIIA-B NSCLC
VIENNA -- The addition of neoadjuvant nivolumab (Opdivo) to chemotherapy significantly improved outcomes in patients with resectable stage…
Trending